From Sarah Haywood, MedCity’s Chief Executive Officer
Open for Business
“May you live in interesting times” is an expression that has resonated strongly over the last few weeks. Apparently, this saying is also known as the Chinese curse, although, according to Wikipedia, there is no actual Chinese source. Whatever the origin, I am sure that many of us can relate to the sentiment, particularly as we emerge from a concentrated period of upheaval in UK national politics.
In the last few days we have seen George Freeman, our Minister for Life Sciences, move to a new role as Chair of the Prime Minister’s policy board. We all look forward to having such an advocate for the sector in a pivotal role, forging government policy.
I would personally like to thank George for his unstinting dedication to life sciences during his tenure as Minister and for the support he has given to MedCity over the last couple of years, including conducting two opening ceremonies for the London Stock Exchange as part of our Future of Healthcare Investment Conferences in 2015 and 2016. We are about to start planning for the 2017 conference and we will miss him next year.
Of course, interesting times also throw up lots of opportunities and periods of change are frequently fertile times for innovation. MedCity continues its mission to ensure that the golden triangle of London, Oxford, Cambridge and the greater south east of England will thrive as a world class centre for research, development, manufacturing and commercialisation. All of the content of this newsletter shows that it is absolutely business as usual. This is why we were delighted to support the Mayor of London’s campaign to communicate that #LondonisOpen.
As we approach the end of July, many of you will be embarking on well deserved summer breaks. We too will be heading off, although writing this on the train to Oxford when it is 32 degrees outside, it is hard to imagine many sunnier climes. There will be no MedCity newsletter in August, but there will be team members available throughout for anyone who wants to engage with us – open for business as usual.
I wish you a good and relaxing break and look forward to updating you on all the fantastic activities and opportunities that exist across our region and the UK when we write out in September.
Collaborate to Innovate (C2N)
C2N is an exciting project in the broad life sciences domain which launched in 2016, part-funded by the European Regional Development Fund.
This summer is witnessing positive developments with regards to the C2N programme, which is being received with enthusiasm from both academics and SMEs with an appetite for collaborations.
C2N is an exciting project in the broad life sciences domain which launched in 2016, part-funded by the European Regional Development Fund. C2N has been set up to help London/UK SMEs achieve applied research/clinical innovations, in domains such as drug discovery, devices, diagnostics, and digital health. We have updated more information about the scheme here: https://medcityhq.com/collaborate-to-innovate/.
C2N has held well-attended awareness-raising events at its academic partners. We have met research groups at UCL, KCL, and QMUL; with an event due at Imperial College due this fall. Based on the discussions at these events and level of interest shown thereafter, the programme has confidence that the academic community will be welcoming expressions of interest from SMEs for joint projects. Initial applications open on September 28.
This date coincides with the SME Launch Event of the C2N programme, which provides more information about the scheme and how to get involved, and will feature examples of collaborations from the project’s academic partners. There will be opportunities for networking and for one-to-one meetings with academics. The event is open for UK SMEs, so register soon as places are limited!
WHEN: Wednesday, 28 September 2016 from 09:30 to 15:00 (BST)
Angels in MedCity companies raise +£8m since launch
The Angels in MedCity programme, a partnership between Angels4LifeSciences, London Business Angels (LBA) and MedCity, was launched at the Wellcome Trust in November 2014 with a first entrepreneur presentation event held in February 2015. The programme was set up to introduce new and existing business angels to early stage and potentially high growth investment opportunities in the medical and life sciences sectors.
Since then we have has supported 35 of the UK’s leading early stage med-tech and life sciences companies, helping 13 of these to raise +£8m of equity funding of which +£2.5m has been invested by Angels in MedCity associated investors. Notably, the supported companies have spanned a range of sectors including digital health, genomics, medical devices and diagnostics and have been based across the UK.
The programme has also held 5 investor workshops in London attended by over 150 interested participants many of whom have gone on to become Angels in MedCity investor participants. Neither participating companies in this investment readiness and investor showcase programme nor participants attending the investor workshops are charged any front end fees.Read more about the programme and the successful companies raising private equity here.
Mayor reassures ambassadors that EU nationals will always be welcome
The Mayor of London, Sadiq Khan, held a round-table for ambassadors from across the continent to reassure them that EU nationals who live in the capital will always be welcome.
The Mayor told ambassadors and senior dignitaries representing the 10 European Union countries with the largest number of nationals living in London that they will continue to play a valuable role in the city.
He also reassured ambassadors that, following the rise in reports of racist or xenophobic abuse in the capital since the EU referendum, he will not tolerate hate crimes of any form, anywhere in London.
MedCity Chief Executive, Sarah Haywood, joined London based technology company, Vision RT, on 7th July as they celebrated 15 years in business and two Queen’s Awards for Enterprise.
The Deputy Lieutenant for the Greater London Lieutenancy, Leslie Morgan OBE, presented the awards on behalf of Her Majesty the Queen; one award for Innovation and the other award for International Trade.
Vision RT develops market-leading technology for surface guided radiotherapy, which particularly benefits breast cancer patients by avoiding cardiac damage and is used to improve comfort and speed during brain treatments. The company, which started from a spare room in north London in 2001, now employs more than 110 people worldwide and supplies its technology to 37 of the top 50 cancer centres in the US. Congratulation to Vision RT’s Chief Executive, Norman Smith and to the Vision RT on this fantastic achievement.
Alternative Careers and Wellbeing for Doctors – Conference 30th September
We are pleased to announce to be official supporters of the annual ‘Alternative Careers and Wellbeing for Doctors’ conference (ACW 2016) on 30 Sept – 1st Oct.
This will be a celebration of diverse careers primarily aimed at medical andhealthcare professionals professionals who are seeking to network and explore exciting opportunities beyond convention. MedCity Newsletter subscribers are offered a 10% discount.
First cohort selected for DigitalHealth.London Accelerator
30 companies have now been selected to form the first cohort of the DigitalHealth.London Accelerator, a major new programme from DigitalHealth.London supporting digital health businesses which would benefit from better engagement with the NHS and the wider health sector.
119 digital health businesses applied to be part of the Accelerator programme, with a shortlist of 64 selected for interview in front of a panel of NHS clinical, technical, digital and commercial experts. The successful 30 companies will be announced at the Accelerator launch on 12 September 2016.
These companies will participate in the year-long programme, which will support them in developing and deploying their products as solutions to some of the most pressing challenges facing health and social care. The support – tailored to specific business needs – focuses on engagement with clinicians and healthcare experts; refining of products to meet needs; deepening understanding of the health system; showcasing in health facilities and developing business models in order to progress product development; and access to the market.
Four NHS Navigators have been appointed to act as relationship managers between the Accelerator cohort and the NHS and wider healthcare sector. They will help each company to navigate the healthcare ecosystem in London, enabling them to access decision makers and support to refine, develop and scale their innovative solutions.
Find out more about the DigitalHealth.London Accelerator programme here.
MedCity was established in April 2014 by the Mayor of London with the Higher Education Funding Council for England and the capital’s three Academic Health Science Centres – Imperial College Academic Health Centre, King’s Health Partners and UCL Partners.
The next edition of MedCity Update will be sent in September.